Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03770689
Title Phase Ib/II Study of M3814 in Combination With Capecitabine and Radiotherapy in Rectal Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors EMD Serono Research & Development Institute, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP

Facility Status City State Zip Country Details
University of Colorado Cancer Center Aurora Colorado 80045 United States Details
Yale University - Pediatric Respiratory Medicine New Haven Connecticut 06520 United States Details
Montefiore Medical Center Bronx New York 10461 United States Details
Northwell Health, Inc Great Neck New York 10042 United States Details
Memorial Sloan-Kettering Cancer Center (MSKCC) - New York New York New York 10065 United States Details
Ohio State University Clinical Trials Management Office - Ohio State CTMO Parent Columbus Ohio 43210 United States Details
University of Toledo Medical Center - Hematology/Oncology Toledo Ohio 43614 United States Details
Med. Univ. of South Carolina Charleston South Carolina 29425 United States Details
Greenville Hospital System University Medical Center (ITOR) Greenville South Carolina 29605 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Hospital Universitari Vall d'Hebron - Dept of Oncology Barcelona Spain Details
Hospital Universitario 12 de Octubre - Servicio de Oncologia Madrid Spain Details
Hospital Regional Universitario de Malaga Málaga Spain Details
Hospital Clinico Universitario de Valencia - Servicio de Hematologia y Oncologia Medica Valencia Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field